Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to evaluate the effect of IgM-enriched immunoglobulins (Pentaglobin) on the endotoxin activity, conventional coagulation parameters, viscoelastic and aggregometric measurements of patients with severe sepsis.
Before the change of the standard operating procedure (SOP) with the implementation of the application of IgM-enriched immunoglobulins to patients with severe sepsis and septic shock conventional inflammatory and coagulation parameters, viscoelastic and aggregometric measurements as well as the endotoxin activity was measured in 15 patients. After the change of SOP the same parameters were recorded for additional 15 patients.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Change in endotoxin activity | The endotoxin activity of the patients was measured with a point of care assay and noted in on an arbitrary scale from 0 to 1.0 | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Changes in CT-NATEM | Changes in clotting time (CT) of the naturally activated rotational thrombelastometry (ROTEM), results were noted in seconds. | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in MCF-NATEM |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Patients with severe sepsis or septic shock in a surgical, tertiary care ICU
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johann Wolfgang Goethe-University | Frankfurt am Main | Hesse | 60590 | Germany |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27504630 | Derived | Wand S, Klages M, Kirbach C, Warszawska J, Meybohm P, Zacharowski K, Koch A. IgM-Enriched Immunoglobulin Attenuates Systemic Endotoxin Activity in Early Severe Sepsis: A Before-After Cohort Study. PLoS One. 2016 Aug 9;11(8):e0160907. doi: 10.1371/journal.pone.0160907. eCollection 2016. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D018805 | Sepsis |
| ID | Term |
|---|---|
| D007239 | Infections |
| D018746 | Systemic Inflammatory Response Syndrome |
| D007249 | Inflammation |
| D010335 | Pathologic Processes |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Changes in maximum clot firmness (MCF) of the naturally activated rotational thrombelastometry (ROTEM), results were noted in millimeters.
| Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in CFT-NATEM | Changes in clot formation time (CFT) of the naturally activated rotational thrombelastometry (ROTEM), results were noted in seconds. | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in NATEM-Alpha angle | Changes in Alpha angle of the naturally activated rotational thrombelastometry (ROTEM), results were noted in °. | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in ADPtest | Platelet activation was measured as the area under the curve of a multiple electrode aggregometry. Platelets were activated using adenosine diphosphate (ADPtest) | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in ASPItest | Platelet activation was measured as the area under the curve of a multiple electrode aggregometry. Platelets were activated using arachidonic acid (ASPItest) | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Changes in TRAPtest | Platelet activation was measured as the area under the curve of a multiple electrode aggregometry. Platelets were activated using thrombin receptor activating peptide (TRAPtest) | Baseline, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78 and 84 hours |
| Platelet count | Platelet count was determined in the clinical routine and noted /nl. | Baseline, 12, 24, 36, 48, 60, 72 and 84 hours |
| Interleukin-6 | Interleukin-6 level was determined in the clinical routine and was noted in pg/ml. | Baseline, 12, 24, 36, 48, 60, 72 and 84 hours |
| Leukocyte count | Leukocyte count was determined in the clinical routine and was noted /µl. | Baseline, 12, 24, 36, 48, 60, 72 and 84 hours |
| Lipopolysaccharide-binding-protein (LBP) | Lipopolysaccharide-binding-protein (LBP) was determined in the clinical routine and was noted in µg/l. | Baseline, 24, 48 and 72 hours |
| D013568 |
| Pathological Conditions, Signs and Symptoms |